Company Filing History:
Years Active: 2019
Title: Innovations of Sangjoon Park
Introduction
Sangjoon Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and recombinant vectors.
Latest Patents
Sangjoon Park holds a patent for a fusion polynucleotide containing a murine CMV promoter. This patent describes a fusion polynucleotide that includes a murine CMV promoter and an intron. It also details a recombinant vector that incorporates the fusion polynucleotide along with a gene encoding a polypeptide of interest. Furthermore, the patent outlines a recombinant cell that contains the recombinant vector and a method for producing a polypeptide of interest using either the recombinant vector or the recombinant cell.
Career Highlights
Sangjoon Park is currently employed at Samsung Bioepis Co., Ltd., where he continues to innovate in the field of biotechnology. His work focuses on enhancing the efficiency of polypeptide production, which has important implications for therapeutic applications.
Collaborations
He collaborates with talented coworkers, including Su Jeong Hwang and Min-Kyung Kim, who contribute to the advancement of their projects and research initiatives.
Conclusion
Sangjoon Park's contributions to biotechnology through his patent and work at Samsung Bioepis Co., Ltd. highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in polypeptide production and therapeutic development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.